CLINICAL_TRIALS
trial_result
· 2025-09-25
Clinical Trial Update: LMN-101 in a Campylobacter Human Challenge Model [Phase 2]
Summary
Phase 2 clinical trial update for LMN-101 in a Campylobacter human challenge model; the study status is COMPLETED and results were posted on 2025-09-25.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lumen Bioscience, Inc. | Conditions: Campylobacter Infections | Phase 2 | Status: COMPLETED | Results posted: 2025-09-25